
OMDA Stock Forecast & Price Target
OMDA Analyst Ratings
Bulls say
Omada Health is poised for success with their unique integrated platform that supports individuals with multiple chronic conditions and a strong focus on retention and expansion through partnerships. They have a track record of delivering measurable health outcomes and have gained attention with their specialized care for GLP-1 medications. Financially, the company has high margins and is expected to continue surpassing expectations as their customer base grows.
Bears say
Omada Health is a next-generation virtual care provider with a comprehensive platform and growing demand for metabolic health management solutions, but its negative outlook is due to concerns about its declining Average Revenue Per User (ARPU) and competition from peers, particularly Hinge Health, DarioHealth, and Vida Health, who have shown strong revenue growth and have partnerships with major health plans and employers. Additionally, while Omada is well-positioned in the dynamic and growing cardiometabolic market, its relatively low multiple valuation compared to its peers is a cause for concern.
This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.
OMDA Analyst Forecast & Price Prediction
Start investing in OMDA
Order type
Buy in
Order amount
Est. shares
0 shares